Anavex Life Sciences Corp (AVXL)

[falconer66a]

Blarcamesine Will Come Out Way Ahead

Does this [the new Anavex Alzheimer's drug trials procedures} mean the drug did not meet its primary endpoints so he is submitting criteria on other indicators?

Not at all. Quite the opposite. It means that when the FDA assesses the six new proposed drug trial metrics blarcamesine will come out way ahead of the competition, the monoclonal antibody drugs. They won't be able to match or beat blarcamesine. Gotta do the assessments to show that; the thrust of the new proposals.